MSR1 and central nervous system cancer: For example, the M2-specific CD204 marker’s presence was associated with poor prognosis in patients with pancreatic adenocarcinoma, hepatocellular carcinoma, and lung adenocarcinoma, suggesting that the pro-tumorigenic role of M2 TAMs is not only restricted to gliomas but extends extracranially as well [37].